The Elixir — mixed-use development
Feasibility and commercial structuring for a mixed-use development of ₹950–1,200 Cr. Attributed to RedDot Life.
Home / Results
Results
No client logos. The operating record instead.
Keel Partners is pre-launch. Until an engagement closes and the client agrees to be named, this page carries only what can be evidenced: what the people here have built and run, and the advisory mandates they have delivered.
>₹100 Cr
Assets under management, built at RedDot Life from a 2020 start.
18.5%
Reported average annual return over the same period.
₹950–1,200 Cr
Development value covered by The Elixir feasibility and commercial structuring mandate.
Advisory mandates
Two mandates, described as they were.
Real estate
Healthcare
Healthcare growth mandate
Scope expanded from ₹3 Cr to ₹4.5 Cr, on a retainer plus a share of incremental revenue. Attributed to RedDot Life.
Operating record
Where the experience comes from
| Organisation | What it involved |
|---|---|
| RedDot Life (2020–) | Founded and built to more than ₹100 Cr AUM with an 18.5% reported average annual return; advisory mandates in real estate and healthcare. |
| Kohler, Asian Paints, IFB | Operating and commercial roles in manufacturing and consumer industrials. |
| 5th Vital, Digifra | Venture and operating involvement in health technology and digital services. |
| Oracle, HP, CallHealth | Enterprise technology and healthcare delivery operations. |
| HP, SAP Labs | Technology, process and platform engineering leadership. |
Why this page looks like this
A firm that has not yet delivered a client engagement cannot honestly show client proof. Publishing the operating record is the alternative we are comfortable defending. The first long-form case study appears here as soon as an engagement closes and the client agrees to be named.
Next step
A 45-minute briefing, no fee, no deck.
Bring the decision you are trying to make. We will tell you whether we are the right firm for it, and what we would do in the first thirty days.